Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ning Lou

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 27, 2017
Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1AWen Xiao, Ning Lou, Hailong Ruan, et al.
Urologic Oncology|September 17, 2016
miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinomaNing Lou, An-Ming Ruan, Bin Qiu, et al.
BMC Cancer|January 24, 2018
Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinomaGuang-Hua Xu, Ning Lou, Hang-Chuan Shi, et al.
Cancer Immunology, Immunotherapy : CII|November 24, 2021
Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapyQiaoyun Tan, Liyuan Dai, Yanrong Wang, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 27, 2017
Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1AWen Xiao, Ning Lou, Hailong Ruan, et al.
Urologic Oncology|September 17, 2016
miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinomaNing Lou, An-Ming Ruan, Bin Qiu, et al.
BMC Cancer|January 24, 2018
Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinomaGuang-Hua Xu, Ning Lou, Hang-Chuan Shi, et al.
Cancer Immunology, Immunotherapy : CII|November 24, 2021
Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapyQiaoyun Tan, Liyuan Dai, Yanrong Wang, et al.
Pageof 13